Here are the 10-K annual reports from Vivos Therapeutics, Inc. (VVOS) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-K covers the audited annual report, with the full financial statements, so if you follow VVOS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full VVOS filings page.
Vivos Therapeutics, Inc. files its annual report describing a major pivot from a legacy dentist-focused distribution model to a medical-provider focused strategy built around sleep centers and managed service organizations. The company acquired The Sleep Center of Nevada (SCN) in June 2025 and is integrating its seven locations into the Vivos platform.
SCN generated $4.8 million of diagnostic revenue and $2.0 million of treatment revenue in 2025, and Vivos plans to scale operations using dedicated Sleep Optimization teams. Management highlights substantial risks, including a history of operating losses, the need for additional capital, integration and regulatory challenges, and dependence on insurance reimbursement and acceptance of The Vivos Method.